癌症治疗学的媒体报道:文献综述

IF 2 Q3 HEALTH POLICY & SERVICES Journal of Cancer Policy Pub Date : 2023-06-01 DOI:10.1016/j.jcpo.2023.100418
Fidel Rubagumya , Jacqueline Galica , Eulade Rugengamanzi , Brandon A. Niyibizi , Ajay Aggarwal , Richard Sullivan , Christopher M. Booth
{"title":"癌症治疗学的媒体报道:文献综述","authors":"Fidel Rubagumya ,&nbsp;Jacqueline Galica ,&nbsp;Eulade Rugengamanzi ,&nbsp;Brandon A. Niyibizi ,&nbsp;Ajay Aggarwal ,&nbsp;Richard Sullivan ,&nbsp;Christopher M. Booth","doi":"10.1016/j.jcpo.2023.100418","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Information and stories about cancer treatment are increasingly available to patients and the general public through lay media, websites, blogs and social media. While these resources may be helpful to supplement information provided during physician-patient discussions, there is growing concern about the extent to which media reports accurately reflect advances in cancer care. This review aimed to understand the landscape of published research which has described media coverage of cancer treatments.</p></div><div><h3>Methods</h3><p>This literature review included peer-reviewed primary research articles that reported how cancer treatments are portrayed in the lay media. A structured literature search of Medline, EMBASE and Google Scholar was performed. Potentially eligible articles were reviewed by three authors for inclusion. Three reviewers, each independently reviewed eligible studies; discrepancies were resolved by consensus.</p></div><div><h3>Results</h3><p>Fourteen studies were included. The content of the eligible studies reflected two thematic categories: articles that reviewed specific drugs/cancer treatment (n = 7) and articles that described media coverage of cancer treatment in general terms (n = 7). Key findings include the media’s frequent and unfounded use of superlatives and hype for new cancer treatments. Parallel to this, media reports over-emphasize potential treatment benefits and do not present a balanced view of risks of side effects, cost, and death. At a broad level, there is emerging evidence that media reporting of cancer treatments may directly impact patient care and policy-making.</p></div><div><h3>Conclusions</h3><p>This review identifies problems in current media reports of new cancer advances – especially with undue use of superlatives and hype. Given the frequency with which patients access this information and the potential for it to influence policy, there is a need for additional research in this space in addition to educational interventions with health journalists. The oncology community – scientists and clinicians – must ensure that we are not contributing to these problems.</p></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Media coverage of cancer therapeutics: A review of literature\",\"authors\":\"Fidel Rubagumya ,&nbsp;Jacqueline Galica ,&nbsp;Eulade Rugengamanzi ,&nbsp;Brandon A. Niyibizi ,&nbsp;Ajay Aggarwal ,&nbsp;Richard Sullivan ,&nbsp;Christopher M. Booth\",\"doi\":\"10.1016/j.jcpo.2023.100418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Information and stories about cancer treatment are increasingly available to patients and the general public through lay media, websites, blogs and social media. While these resources may be helpful to supplement information provided during physician-patient discussions, there is growing concern about the extent to which media reports accurately reflect advances in cancer care. This review aimed to understand the landscape of published research which has described media coverage of cancer treatments.</p></div><div><h3>Methods</h3><p>This literature review included peer-reviewed primary research articles that reported how cancer treatments are portrayed in the lay media. A structured literature search of Medline, EMBASE and Google Scholar was performed. Potentially eligible articles were reviewed by three authors for inclusion. Three reviewers, each independently reviewed eligible studies; discrepancies were resolved by consensus.</p></div><div><h3>Results</h3><p>Fourteen studies were included. The content of the eligible studies reflected two thematic categories: articles that reviewed specific drugs/cancer treatment (n = 7) and articles that described media coverage of cancer treatment in general terms (n = 7). Key findings include the media’s frequent and unfounded use of superlatives and hype for new cancer treatments. Parallel to this, media reports over-emphasize potential treatment benefits and do not present a balanced view of risks of side effects, cost, and death. At a broad level, there is emerging evidence that media reporting of cancer treatments may directly impact patient care and policy-making.</p></div><div><h3>Conclusions</h3><p>This review identifies problems in current media reports of new cancer advances – especially with undue use of superlatives and hype. Given the frequency with which patients access this information and the potential for it to influence policy, there is a need for additional research in this space in addition to educational interventions with health journalists. The oncology community – scientists and clinicians – must ensure that we are not contributing to these problems.</p></div>\",\"PeriodicalId\":38212,\"journal\":{\"name\":\"Journal of Cancer Policy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213538323000358\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538323000358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 1

摘要

背景癌症治疗的信息和故事越来越多地通过非专业媒体、网站、博客和社交媒体提供给患者和公众。虽然这些资源可能有助于补充在医生和患者讨论中提供的信息,但人们越来越担心媒体报道在多大程度上准确反映了癌症护理的进展。这篇综述旨在了解已发表研究的概况,该研究描述了媒体对癌症治疗的报道。方法这篇文献综述包括同行评议的主要研究文章,这些文章报道了非专业媒体对癌症治疗的描述。对Medline、EMBASE和Google Scholar进行了结构化文献检索。三位作者对可能符合条件的文章进行了审查,以供纳入。三名评审员,每个评审员独立评审合格研究;分歧以协商一致的方式得到解决。结果纳入14项研究。符合条件的研究的内容反映了两个主题类别:回顾特定药物/癌症治疗的文章(n=7)和描述媒体对癌症治疗的一般报道的文章(n=7)。主要发现包括媒体频繁和毫无根据地使用最高级,以及对癌症新治疗方法的炒作。与此同时,媒体报道过分强调了潜在的治疗益处,并没有对副作用、成本和死亡的风险提出平衡的看法。在广泛的层面上,有新的证据表明,媒体对癌症治疗的报道可能会直接影响患者护理和政策制定。结论这篇综述指出了当前媒体对癌症新进展的报道中存在的问题,尤其是过度使用最高级和炒作。鉴于患者获取这些信息的频率及其影响政策的潜力,除了与卫生记者进行教育干预外,还需要在这一领域进行更多的研究。肿瘤学界——科学家和临床医生——必须确保我们不会助长这些问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Media coverage of cancer therapeutics: A review of literature

Background

Information and stories about cancer treatment are increasingly available to patients and the general public through lay media, websites, blogs and social media. While these resources may be helpful to supplement information provided during physician-patient discussions, there is growing concern about the extent to which media reports accurately reflect advances in cancer care. This review aimed to understand the landscape of published research which has described media coverage of cancer treatments.

Methods

This literature review included peer-reviewed primary research articles that reported how cancer treatments are portrayed in the lay media. A structured literature search of Medline, EMBASE and Google Scholar was performed. Potentially eligible articles were reviewed by three authors for inclusion. Three reviewers, each independently reviewed eligible studies; discrepancies were resolved by consensus.

Results

Fourteen studies were included. The content of the eligible studies reflected two thematic categories: articles that reviewed specific drugs/cancer treatment (n = 7) and articles that described media coverage of cancer treatment in general terms (n = 7). Key findings include the media’s frequent and unfounded use of superlatives and hype for new cancer treatments. Parallel to this, media reports over-emphasize potential treatment benefits and do not present a balanced view of risks of side effects, cost, and death. At a broad level, there is emerging evidence that media reporting of cancer treatments may directly impact patient care and policy-making.

Conclusions

This review identifies problems in current media reports of new cancer advances – especially with undue use of superlatives and hype. Given the frequency with which patients access this information and the potential for it to influence policy, there is a need for additional research in this space in addition to educational interventions with health journalists. The oncology community – scientists and clinicians – must ensure that we are not contributing to these problems.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
期刊最新文献
Income disparities have a significant impact on thyroid cancer recurrence and survival An assessment of cancer centre level designation and guideline adherent care in those with rectal cancer: A population based retrospective cohort study Spending on anticancer drugs among Medicare beneficiaries: Analyzing predictors of drug expenditures Barriers to identifying and addressing health-related social needs in cancer care: Patient and patient navigator perspectives Analysis of factors associated with use of real-world data in single technology appraisals of cancer drugs by the National Institute for Health and Care Excellence
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1